Chad Gassert - Jul 1, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Jul 1, 2024
Transactions value $
-$1,268,800
Form type
4
Date filed
7/2/2024, 08:58 PM
Previous filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$1.27M -20K -9.38% $63.44 193K Jul 1, 2024 Held by Chali Properties LLC F1, F2, F3
holding ANIP Common Stock 49.7K Jul 1, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023.
F2 The shares were sold in multiple trades at prices ranging from $62.81 to $64.11. The price reported above reflects the weighted average sales price.
F3 The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.